Guggenheim Maintains Krystal Biotech (KRYS) Buy Recommendation
23/5 10:23
Fintel reports that on May 22, 2023, Guggenheim maintained coverage of Krystal Biotech (NASDAQ:KRYS) with a Buy recommendation....
|
|
|
23/5 10:23
Fintel reports that on May 22, 2023, Guggenheim maintained coverage of Krystal Biotech (NASDAQ:KRYS) with a Buy recommendation....